← Leaderboards
Udayan Y Bhatt
Ohio State University
$608,512
Attributed
$608,512
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $130.4K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$608,512 · 2
By mechanism
K08$518,536 · 1
F32$89,976 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Jianrong Li$9,360,578
- Kwame Osei$754,133
- Brad H Rovin$10,724,088
- Patrick Lee Green$10,720,230
- Jane Elizabeth Jackman$6,635,073
Others in their field
Top investigators on “Recombinant Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$93,946,116
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Thomas William Geisbert · Boston University Medical Campus$51,555,223
- Elizabeth Baseler · Leidos Biomedical Research, Inc.$40,046,035
- Ralph S Baric · University Of North Carolina Chapel Hill$38,977,787
- John P Moore · Weill Medical College Of Cornell Univ$37,100,759
Research focus
Recombinant VirusAdenoviridaeDiabetic NephropathyLaboratory RatGene TherapyDiabetes Mellitus TherapyVirus ReceptorsMethod DevelopmentCoxsackievirusGenetic TransductionKidney CellMicroarray TechnologyPolymerase Chain ReactionReceptor ExpressionGlomerulosclerosisProtein LocalizationWestern BlottingsHuman TissueTissue /Cell CultureImmunocytochemistryTransfection /Expression VectorNorthern Blottings
Grant awards (7)
CAR & adenoviral gene therapy for diabetic renal disease$130,384
K08 · FY2006 · DK · contact PI
CAR &adenoviral gene therapy for diabetic renal disease$129,384
K08 · FY2005 · DK
CAR &adenoviral gene therapy for diabetic renal disease$96,411
K08 · FY2004 · DK
CAR &adenoviral gene therapy for diabetic renal disease$32,973
K08 · FY2004 · DK
CAR &adenoviral gene therapy for diabetic renal disease$129,384
K08 · FY2003 · DK
ROLE OF ADENOVIRAL RECEPTORS IN GENE THERAPY OF DIABETES$47,348
F32 · FY2001 · DK
ROLE OF ADENOVIRAL RECEPTORS IN GENE THERAPY OF DIABETES$42,628
F32 · FY2000 · DK